Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:50 PM UTC
| NCT Number | NCT05320198 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Disc Medicine, Inc |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 17, 2026: Clinical trial NCT05320198 is currently recruiting participants. This phase1 study for myelofibrosis is actively seeking new participants at 22 locations across the United States. The study is sponsored by Disc Medicine, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05320198 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05320198 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.